UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Series A	Series A-1	Series B Preferred Stock	Class A Common Stock	Class A Common Stock Common Stock	Class A Common Stock Additional Paid-in Capital	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2020						3,379,400	1,837,600
Beginning balance at Dec. 31, 2020						$ 7,789	$ 10,270
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of preferred stock (in shares)						(3,379,400)	(1,837,600)
Conversion of preferred stock						$ (7,789)	$ (10,270)
Ending balance (in shares) at Mar. 31, 2021						0	0
Ending balance at Mar. 31, 2021						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2020								4,681,400
Beginning balance (in shares) at Dec. 31, 2020		95,050,041								0			0
Beginning balance at Dec. 31, 2020	$ (6,840)	$ 0	$ 4,975	$ 0	$ (35,815)			$ 24,000		$ 0			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)		29,695,200						(4,681,400)
Conversion of preferred stock	18,058		42,058					$ (24,000)
Issuance of Class A Common Stock in connection with the initial public offering, net of issuance costs (in shares)										10,000,000
Issuance of Class A Common Stock in connection with the initial public offering, net of issuance costs	126,622		126,622
Reclassification of Common Stock to Class B Common Stock in connection with the initial public offering (in shares)		(124,745,241)											124,745,241
Reclassification of Common Stock to Class B Common Stock in connection with the initial public offering	0		(1)										$ 1
Exercise of stock options (in shares)													3,861
Exercise of stock options	7		7
Stock-based compensation expense	593		593
Net (loss) income	1,471				1,471
Ending balance (in shares) at Mar. 31, 2021								0
Ending balance (in shares) at Mar. 31, 2021		0								10,000,000			124,749,102
Ending balance at Mar. 31, 2021	139,911	$ 0	174,254	0	(34,344)			$ 0		$ 0			$ 1
Beginning balance (in shares) at Dec. 31, 2020						3,379,400	1,837,600
Beginning balance at Dec. 31, 2020						$ 7,789	$ 10,270
Ending balance (in shares) at Sep. 30, 2021						0	0
Ending balance at Sep. 30, 2021						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2020								4,681,400
Beginning balance (in shares) at Dec. 31, 2020		95,050,041								0			0
Beginning balance at Dec. 31, 2020	(6,840)	$ 0	4,975	0	(35,815)			$ 24,000		$ 0			$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Foreign currency translation adjustments	0
Net (loss) income	577
Ending balance (in shares) at Sep. 30, 2021								0
Ending balance (in shares) at Sep. 30, 2021		0								21,986,619			114,105,779
Ending balance at Sep. 30, 2021	150,055	$ 0	185,292	0	(35,238)			$ 0		$ 0			$ 1
Beginning balance (in shares) at Mar. 31, 2021						0	0
Beginning balance at Mar. 31, 2021						$ 0	$ 0
Ending balance (in shares) at Jun. 30, 2021						0	0
Ending balance at Jun. 30, 2021						$ 0	$ 0
Beginning balance (in shares) at Mar. 31, 2021								0
Beginning balance (in shares) at Mar. 31, 2021		0								10,000,000			124,749,102
Beginning balance at Mar. 31, 2021	139,911	$ 0	174,254	0	(34,344)			$ 0		$ 0			$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)										81,102			(81,102)
Issuance of Class A Common Stock in connection with the initial public offering, net of issuance costs (in shares)										719,266
Issuance of Class A Common Stock in connection with the initial public offering, net of issuance costs	9,245		9,245
Exercise of stock options (in shares)													28,442
Exercise of stock options	19		19
Stock-based compensation expense	569		569
Net (loss) income	(279)				(279)
Ending balance (in shares) at Jun. 30, 2021								0
Ending balance (in shares) at Jun. 30, 2021		0								10,800,368			124,696,442
Ending balance at Jun. 30, 2021	149,465	$ 0	184,087	0	(34,623)			$ 0		$ 0			$ 1
Ending balance (in shares) at Sep. 30, 2021						0	0
Ending balance at Sep. 30, 2021						$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)										11,186,251			(11,186,251)
Exercise of stock options (in shares)													543,826
Exercise of stock options	578		578
Stock-based compensation expense	627		627
Foreign currency translation adjustments	0
Vesting of Class A & B Common Stock in connection with Restricted Stock Units (in shares)													51,762
Net (loss) income	(615)				(615)
Ending balance (in shares) at Sep. 30, 2021								0
Ending balance (in shares) at Sep. 30, 2021		0								21,986,619			114,105,779
Ending balance at Sep. 30, 2021	$ 150,055	$ 0	185,292	0	(35,238)			$ 0		$ 0			$ 1
Beginning balance (in shares) at Dec. 31, 2021						0	0
Beginning balance at Dec. 31, 2021						$ 0	$ 0
Ending balance (in shares) at Mar. 31, 2022						0	0
Ending balance at Mar. 31, 2022						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2021	0							0
Beginning balance (in shares) at Dec. 31, 2021		0							31,841,061	31,841,061		108,870,126	108,870,126
Beginning balance at Dec. 31, 2021	$ 225,542	$ 0	264,871	(230)	(39,100)			$ 0		$ 0			$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)										10,842,862			(10,842,862)
Exercise of stock options (in shares)										197,828
Exercise of stock options	924		924
Stock-based compensation expense	932		932
Issuance of shares in connection with Employee Stock Purchase Plan (in shares)										39,516
Vesting of Class A & B Common Stock in connection with Restricted Stock Units (in shares)										14,625
Cumulative translation adjustment	(264)			(264)
Net (loss) income	(2,571)				(2,571)
Ending balance (in shares) at Mar. 31, 2022								0
Ending balance (in shares) at Mar. 31, 2022		0								42,935,892			98,027,264
Ending balance at Mar. 31, 2022	$ 224,563	$ 0	266,727	(494)	(41,671)			$ 0		$ 0			$ 1
Beginning balance (in shares) at Dec. 31, 2021						0	0
Beginning balance at Dec. 31, 2021						$ 0	$ 0
Ending balance (in shares) at Sep. 30, 2022						0	0
Ending balance at Sep. 30, 2022						$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2021	0							0
Beginning balance (in shares) at Dec. 31, 2021		0							31,841,061	31,841,061		108,870,126	108,870,126
Beginning balance at Dec. 31, 2021	$ 225,542	$ 0	264,871	(230)	(39,100)			$ 0		$ 0			$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)	605,950
Foreign currency translation adjustments	$ (1,230)
Net (loss) income	(19,947)
Ending balance (in shares) at Sep. 30, 2022								0
Ending balance (in shares) at Sep. 30, 2022		0							43,615,053	43,615,053		97,864,674	97,864,674
Ending balance at Sep. 30, 2022	211,277	$ 0	271,783	(1,460)	(59,047)			$ 0		$ 0			$ 1
Beginning balance (in shares) at Mar. 31, 2022						0	0
Beginning balance at Mar. 31, 2022						$ 0	$ 0
Ending balance (in shares) at Jun. 30, 2022						0	0
Ending balance at Jun. 30, 2022						$ 0	$ 0
Beginning balance (in shares) at Mar. 31, 2022								0
Beginning balance (in shares) at Mar. 31, 2022		0								42,935,892			98,027,264
Beginning balance at Mar. 31, 2022	224,563	$ 0	266,727	(494)	(41,671)			$ 0		$ 0			$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)										156,600			(156,600)
Exercise of stock options (in shares)										143,667
Exercise of stock options	270		270
Stock-based compensation expense	2,204		2,204
Foreign currency translation adjustments	(857)			(857)
Vesting of Class A & B Common Stock in connection with Restricted Stock Units (in shares)										25,024
Net (loss) income	(8,284)				(8,284)
Ending balance (in shares) at Jun. 30, 2022								0
Ending balance (in shares) at Jun. 30, 2022		0								43,261,183			97,870,664
Ending balance at Jun. 30, 2022	217,896	$ 0	269,201	(1,351)	(49,955)			$ 0		$ 0			$ 1
Ending balance (in shares) at Sep. 30, 2022						0	0
Ending balance at Sep. 30, 2022						$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of preferred and common stock (in shares)										57,749			(57,749)
Exercise of stock options (in shares)										264,455
Exercise of stock options	345		345
Stock-based compensation expense	1,980		1,980
Foreign currency translation adjustments	$ (109)
Issuance of shares in connection with Employee Stock Purchase Plan (in shares)	257,000									25,240	257,000
Vesting of Class A & B Common Stock in connection with Restricted Stock Units (in shares)	103,521									6,426			51,759
Cumulative translation adjustment	$ (109)			(109)
Net (loss) income	(9,092)				(9,092)
Ending balance (in shares) at Sep. 30, 2022								0
Ending balance (in shares) at Sep. 30, 2022		0							43,615,053	43,615,053		97,864,674	97,864,674
Ending balance at Sep. 30, 2022	$ 211,277	$ 0	$ 271,783	$ (1,460)	$ (59,047)			$ 0		$ 0			$ 1